domingo, 24 de abril de 2022

Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything? EJ Lelliot et al, NPJ Precision Oncology, April 20, 2022

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario